Bruna David: Disparities in the treatment of rare cancers in Latin America
Bruna David, Medical oncologist specializing in sarcoma and GIST at Oncoclinics Group, posted on LinkedIn about recent paper by her as co-author, titled “Assessment of Rare Cancers and Sarcoma Policy and Sarcoma Drug Approvals in Latin America: A Report From the LACOG Sarcoma Group” published on ASCO Publications.
Authors: Douglas Dias e Silva, Bruna Bianca Lopes David, Veridiana Pires de Camargo, Renee Zon Filipi, María Lucila Gonzalez Donna, Juan Carlos Haro Varas, Rodrigo Ramella Munhoz, Maycos L. Zapata, Cicero Luiz Cunha Martins, Matias Chacon, Rafael Schmerling, Reynaldo Jesus Garcia, Roberto Carmagnani Pestana
“Just out the article from the LACOG Sarcoma Group on disparities in the treatment of rare cancers in Latin America. We included a focused analysis on drug approvals for Sarcomas in the region, and the lack of policies for rare diseases in local national cancer control plans.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023